Healthcare & Life Sciences
Trogenix
United Kingdomtrogenix.com
Trogenix is a startup based in the United Kingdom, most recent round Series A, 2 tracked investors.
activeseries-a
series-a
Stage
2018
Founded
2
Investors
About Trogenix
Trogenix is a company founded in 2018 headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Trogenix Ltd is a clinical-stage oncology company developing precision cancer therapies using its proprietary Synthetic Super-Enhancer (SSE) technology, targeting aggressive solid tumors like glioblastoma with a potentially curative, one-time treatment approach.
Explore Trogenix's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.